Comparing the viscoelastomeric fibrin polymerization assays FIBTEM^® (ROTEM) vs. Functional Fibrinogen^® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one?

Articles in the same Issue

1. Frontmatter
2. Editorials
3. The Theranos phenomenon, scientific transparency and freedom of speech
4. Holotranscobalamin: in the middle of difficultly lies opportunity
5. Review
6. Laboratory and clinical risk assessment to treat myelodysplatic syndromes
7. Mini Review
8. Quantitative nucleic acid amplification by digital PCR for clinical viral diagnostics
9. Genetics and Molecular Diagnostics
10. Hybrid minigene splicing assay verified the pathogenicity of a novel splice site variant in the dystrophin gene of a Chinese patient with typical Duchenne muscular dystrophy phenotype
11. General Clinical Chemistry and Laboratory Medicine
12. Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension
13. Sex steroid hormone stability in serum tubes with and without separator gels
14. Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols
15. An International Standard for holotranscobalamin (holoTC): international collaborative study to assign a holoTC value to the International Standard for vitamin B12 and serum folate
16. A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screening
17. Investigation on the ability of first trimester glycodelin and angiopoietin-2 to predict small-for-gestational age pregnancies at delivery
18. Plasma total C-terminal agrin fragment (tCAF) as a marker for kidney function in patients with chronic kidney disease
19. Hematology and Coagulation
20. Thirty-minutes’ exposure to smartphone call triggers neutrophil activation in vitro
21. Performance of the XN-2000 WPC channel-flagging to differentiate reactive and neoplastic leukocytosis
22. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation
23. Reference Values and Biological Variations
24. Derivation of level-specific reference change values (RCV) from a health screening database and optimization of their thresholds based on clinical utility
25. Cancer Diagnosis
26. BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience
27. Letters to the Editor
28. Significant increase of serum prostate-specific antigen after exercise
29. Serum delipidation but not high-speed centrifugation is effective in clearing lipemia interference in serum lipase activity measurement
30. A relationship between absolute monocyte count and C-reactive protein in patients with migraine undergoing no pharmacological therapy
31. Validation of the “Vacutainer^® urinalysis preservative plus urine tube” for the determination of albumin and protein
32. Performance evaluation of a novel automated HIV Ag/Ab chemiluminescence immunoassay
33. SLC26A4 genotypes associated with enlarged vestibular aqueduct malformation in south Italian children with sensorineural hearing loss
34. Is cystatin C level altered in women with polycystic ovary syndrome?
35. Venous thromboembolism in a patient with persistent inhibitor to coagulation factor V – a case report
36. Free light chains nephelometric assay: human urine stability in different storage conditions
37. Comparing the viscoelastomeric fibrin polymerization assays FIBTEM^® (ROTEM) vs. Functional Fibrinogen^® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one?
38. Reply to: Comparing the visco-elastomeric fibrin polymerization assays FIBTEM^® (ROTEM) vs. Functional Fibrinogen^® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one? By Schöchl et al.
39. Congress Abstracts
40. 5^th Slovenian Congress of Clinical Chemistry and Laboratory Medicine